NAD(P)H:quinone oxidoreductase (NQO1) plays a dominant role in the reduction of the quinone compound 2,3,5,6-tetramethyl-1,4-benzoquinone (duroquinone, DQ) to durohydroquinone (DQH 2 ) on passage through the rat lung. Exposure of adult rats to sublethal hyperoxia (85% O 2 ) for seven or more days stimulates adaptation to the otherwise lethal effects of > 95% O 2 . The objective of this study was to examine whether exposure of adult rats to hyperoxia (85% O 2 for 48 hours or 21 days) affected lung NQO1 activity as measured by the rate of DQ reduction on passage through the lung. We measured the appearance of DQH 2 in the venous effluent during DQ infusion at different concentrations into the pulmonary artery of isolated perfused lungs from rats that had been exposed to room air or to 85% O 2 . We also evaluated the effect of hyperoxia on vascular transit time distribution, and measured NQO1 activity and protein in lung homogenate. The results demonstrate that exposure to 85% O 2 for 21 days increases lung capacity to reduce DQ to DQH 2 , and that NQO1 is the dominant DQ reductase in normoxic and hyperoxic lungs. Kinetic analysis revealed that 21 day hyperoxia exposure increased the maximum rate of pulmonary DQ reduction, V max , from 1.95 ± 0.14 (SE) to 4.04 ± 0.21 µmol/min, and the apparent Michaelis-Menten constant for DQ reduction, K ma , from 44 ± 11 to 149 ± 11 µM. The increase in V max suggests a hyperoxia-induced increase in NQO1 activity of lung cells accessible to DQ from the vascular region, consistent qualitatively but not quantitatively with an increase in lung homogenate NOQ1 activity in 21-day hyperoxic lungs (~34%). The increase in K ma could be accounted for by ~ 40 % increase in vascular transit time heterogeneity in 21-day hyperoxic lungs.
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thereby ameliorating the effects of semiquinone formation and subsequent redox cycling (9, 33) , and scavenging superoxide (30) .
The model quinone duroquinone (DQ) is one of several redox active compounds that we have used to probe pulmonary endothelial surface and intracellular redox enzymes in the intact lung using indicator dilution methods (1, 2, 4, 6) . We have demonstrated that NQO1 plays a dominant role in DQ reduction to its two-electron reduction product durohydroquinone (DQH 2 ) on a single pass through the rat pulmonary circulation (1). The present study examines whether exposure of adult rats to hyperoxia (85% O 2 for 48 hours or 21 days) affects NQO1 activity in the intact rat lung as measured by the rate of DQ reduction on passage through the lungs. The main approach we took was to measure the rate of appearance of DQH 2 in the venous effluent during DQ infusion at different concentrations into the pulmonary artery of isolated perfused lungs from normal rats and from rats that had been exposed to 85% O 2 for 48 hours or 21 days.
We also evaluated the effect of rat exposure to hyperoxia on vascular transit time heterogeneity, and measured NQO1 protein and activity in lung homogenate. The results demonstrate increased DQ reduction capacity in lungs of rats exposed to hyperoxia for 21 days, and provide insights into the effects of hyperoxia-induced increase in pulmonary vascular transit time heterogeneity on steady state Michaelis-Menten kinetics.
Methods:

Materials:
Duroquinone (DQ) was purchased from Sigma Chemical Company (St. Louis, MO). Bovine serum albumin (Standard Powder, BSA) was purchased from Serologicals Corp. (Gaithersburg, MD). Durohydroquinone (DQH 2 ) was prepared by reduction of DQ
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with potassium borohydride (KBH 4 ) as previously described (10) . Other chemicals were purchased from Sigma Chemical Company and were of reagent grade.
Hyperoxic exposure:
Adult Sprague-Dawley rats (Charles River) (250-350 grams) were housed in a sealed Plexiglas chamber (13W x 23L x 12H inches) with ~ 85% O 2 balance N 2 for 48 hours (final body wt, 326 ± 5 (SE) g, n = 10) or 21 days (final body wt, 290 ± 8 g, n = 14). The total gas flow of ~ 3.5 liters/min was high enough to maintain the chamber CO 2 at < 0.5 %. The animals were maintained on a 12 hour light-dark cycle with free access to food and water, which along with bedding, were changed every other day. Control (normoxic) animals (final body wt, 324 ± 6 g, n = 21) were exposed to room air. The protocol was approved by the Institutional Animal Care and Use Committees of the Veterans Affairs Medical Center and Marquette University (Milwaukee, WI).
The 48 hours exposure period was chosen to evaluate hyperoxia-induced changes in lung DQ reduction rate, and lung NQO1 protein and activity prior to the development of tolerance to lethal hyperoxia (> 95% O 2 ) (14, 15) . The 21-day exposure period was chosen because it is long enough to stimulate adaptation to >95% O 2 (14, 15) , and to reverse the body weight loss that occurs during the first 2 weeks of exposure to 85% O 2 (14) . Lungs of control rats will be referred to as normoxic lungs, and lungs of rats exposed to hyperoxic gas mixture for 48 hours or 21 days as 48-hour hyperoxic lungs and 21-day hyperoxic lungs, respectively.
Isolated perfused lung experiments:
The isolated perfused rat lung preparation has been described previously (1).
Briefly, each rat was anesthetized with pentobarbital sodium (40 mg/kg body wt. i.p.),
6/24/2005
after which the trachea was clamped and the chest opened. Heparin (0.7 IU/g body wt.) was injected into the right ventricle. The pulmonary artery and the trachea were cannulated, and the pulmonary venous outflow was accessed via a cannula in the left atrium. The lungs were removed from the chest and attached to a ventilation and perfusion system. The perfusate (referred to as control perfusate) was a physiological salt solution containing (in mM) 4.7 KCl, 2.51 CaCl 2 , 1.19 MgSO 4 , 2.5 KH 2 PO 4 , 118 NaCl, 25 NaHCO 3 , 5.5 glucose, and 5% BSA (1).
The single pass perfusion system was primed with control perfusate maintained at 37° C and equilibrated with 15% O 2 , 6% CO 2 , balance N 2 resulting in perfusate PO 2 , PCO 2 and pH of ~ 105 Torr, 40 Torr, and 7.4, respectively. Initially, perfusate was pumped (Master Flex roller pump) through the lungs until the lungs were evenly blanched and venous effluent was visually clear of blood. The flow rate was then set at 10 ml/min. The lungs were ventilated (40 breaths/min) with end inspiratory and expiratory pressures of 6 and 3 mmHg, respectively, with the above gas mixture. The pulmonary arterial pressure was referenced to atmospheric pressure at the level of the left atrium and monitored continuously during the course of the experiments. The venous effluent pressure was atmospheric pressure. At the end of each experiment, the lungs were weighed, and then dried (60 o C) to a constant weight to determine lung dry weight and wet/dry weight ratio. For some lungs, half was homogenized for in vitro determination of NQO1 protein and activity as described below, and the other half was used to determine lung dry weight and wet/dry weight ratio.
To measure the fate of DQ on passage through the lungs, pulse infusion and bolus injection experiments were carried out (1). The pulse infusion experiments provide data
in which information about the steady state aspects of DQ and DQH 2 disposition on passage through the lungs is emphasized, whereas the bolus experiments provide data in which information about the transient aspects of DQ and DQH 2 disposition is emphasized.
Experimental protocols:
Capacity of lungs for DQ reduction:
To determine the DQ reducing capacity of normoxic and hyperoxic lungs, four 60-90 second sequential pulse infusions at DQ concentrations of 50, 100, 200 and 400
µM were carried out on each lung. The pump flow rate was set at 10 ml/min. For each pulse infusion, venous effluent samples (~ 0.5 ml) were collected at 10 second intervals during infusion. Between pulse infusions, the lungs were perfused with about 20 ml of fresh perfusate to wash the perfusion system and the lungs of any remaining traces of DQ and/or DQH 2 from the previous pulse. Multiple DQ pulses and high DQ concentrations did not have significant effect on DQ reduction in subsequent pulses (1).
Inhibitor treatments:
To determine the contribution of NQO1 to DQ reduction in normoxic and hyperoxic lungs, DQ pulse infusions were carried out before and after lung treatment with the NQO1 inhibitor dicumarol (25) . For each lung, a 90 second pulse infusion of 400 µM DQ was performed and venous samples collected as before. This was followed by perfusing the lung with perfusate containing dicumarol (400 µM) for ~ 5 minutes.
Following treatment with dicumarol, another 90 second pulse infusion of DQ (400 µM)
plus dicumarol (400 µM) was performed and venous samples collected as before. The above concentration of dicumarol was needed to inhibit lung NQO1 activity because dicumarol has a high affinity for plasma proteins (34) .
To determine the contribution of DQH 2 oxidation to the net effect of the lung on DQ, the above pulse infusion protocol was repeated in lungs pretreated with cyanide (2 mM) (1). This was accomplished by recirculating perfusate containing cyanide (2 mM) through the lungs for 5 minutes, a dose and time previously determined to be sufficient to inhibit DQH 2 oxidation to DQ on passage through the lungs (1).
Bolus injections:
Bolus injection experiments were carried out to evaluate hyperoxia-induced changes in lung tissue volume accessible to DQH 2 from the vascular space, lung vascular volume and vascular perfusion heterogeneity. An injection loop was included in the arterial line to allow introduction of a 0.1 ml bolus into the arterial inflow without altering the flow or perfusion pressure (1). For each lung, perfusate containing cyanide (2 mM) was recirculated for 5 minutes just prior to bolus injection. The pump flow rate was set at 10 ml/min. The respirator was stopped at end expiration and a bolus of the perfusate solution containing either 400 µM DQH 2 or 35 µM of the vascular reference indicator fluorescein isothiocyanate dextran, FITC-dex, (average mol wt ~ 43,000), was injected. At the same time that the bolus was introduced into the arterial inflow, the venous outflow was diverted into a modified Gilson Escargot fraction collector for continuous collection of the lung effluent (1). Thirty-five venous effluent samples (0.3 ml each) were collected at 1.8 sec intervals. At the end of each experiment, the lungs were removed from the perfusion system, the arterial and venous cannulas connected directly together, and an additional FITC-dex bolus injection was made. These data were used to obtain the tubing transit time and bolus dispersion needed for calculation of the lung vascular volume and the relative dispersion of vascular transit time distribution (see Data Analysis section).
Perfused capillary surface area:
To evaluate hyperoxia-induced changes in pulmonary endothelial surface area, the rate of hydrolysis of the peptide N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly (FAPGG), an angiotensin converting enzyme (ACE) substrate, on a single pass through the pulmonary circulation was measured (27) . were added to samples that emerged in the venous effluent prior to the appearance of the bolus contents. These samples were used as standards for determining the fraction of bolus contents per ml of venous effluent sample.
Lung homogenate NQO1 activity and NQO1 immunoblots
At the end of the DQ reduction studies that did not involve using metabolic inhibitors, the lungs were removed from the perfusion system, weighed and placed on ice.
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Ice cold homogenization buffer (5 ml buffer 
Statistical evaluation of data:
Statistical comparisons between the various experimental conditions were obtained by ANOVA followed by the Dunnett test. P < 0.05 was considered statistically significant. Table 1 shows perfusion pressures, wet weights, dry weights and wet/dry weight ratios of the lungs studied. Exposure to hyperoxia for 21 days increased lung perfusion pressure, wet and dry weights, with small (< 9%) but significant increase in wet/dry weight ratios as compared to normoxic lungs, indicating a slight edema in hyperoxic lungs. Exposure to hyperoxia for 48 hours had no significant effect on any of the above parameters or on any of the parameters described below. Thus, the results presented below are limited to comparisons between normoxic lungs and 21-day hyperoxic lungs.
Results:
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Lung's DQ reducing capacity: Figure 1a shows the effluent concentrations of DQ and DQH 2 
Inhibitor treatments:
To evaluate the contribution of NQO1 to DQ reduction, we examined the effect of dicumarol, an NQO1 inhibitor, on DQ reduction (1, 25). Table 2 shows that dicumarol almost completely (> 96%) inhibited reduction of 400 µM DQ pulse infusion in normoxic and hyperoxic lungs. Bolus injections: 
Perfused capillary surface area:
The steady state rate of FAPGG hydrolysis in a normoxic lung perfused with control perfusate was linear over wide range of FAPGG concentrations that included the concentration (150 µM) used in the present study to calculate a permeability-surface area product, PS, for ACE-medicated FAPGG hydrolysis. Table 4 shows that exposure to hyperoxia for 21 days decreased PS (ml/min) on average by more than 70%, as compared to normoxic lungs. The PS values obtained from FAPGG pulse infusions carried out at the beginning or at the end of a given experimental protocol were not significantly different, indicating that perfusion, multiple DQ pulses, and/or metabolic treatments did not have significant irreversible effects on lung capillary endothelial surface area and/or ACE activity.
Effect of hyperoxia on NQO1 activity and protein: Table 6 shows that exposure to hyperoxia for 21 days significantly increased NQO1 activity in lung homogenate by ~ 34% as compared to normoxic lungs on a per mg protein basis. Figure 4 shows NQO1 immunoblots of normoxic and hyperoxic lung homogenates. Band intensities obtained from 21-day hyperoxic lung homogenates were, on average, more than 3-fold greater than those from normoxic lung homogenates.
Data Analysis:
Kinetic model:
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To interpret the experimental results, a kinetic model previously described (1) was modified to describe the fate of DQ on passage through the lungs. The model consists of a capillary volume (V c ) and its surrounding tissue volume (V e ). The free forms (i.e., not albumin bound) of both DQ and DQH 2 are assumed to be freely permeable into V e (1).
Within V c , the model allows for nonspecific rapidly equilibrating interactions of DQ and DQH 2 with the perfusate albumin, P c , (equations (2)). Within V e , the model allows for two electron DQ reduction to DQH 2 (equation (3)), cyanide-sensitive DQH 2 oxidation to DQ (equation (4)), and nonspecific rapidly equilibrating interactions of DQ and DQH 2 with lung tissue sites of association, P e (equations (5) In perfusate (c):
perfusate albumin, P c , association
In tissue (e):
Rapidly equilibrating associations
where EH and E + are the reduced and oxidized forms, respectively, of intracellular electron donor(s), and the k i 's represent the reaction rate constants.
a. Species Balance:
The above stoichiometric relationships are expressed as species balance equations: For the steady state during the pulse infusion of DQ or DQH 2 , equations (7) and (8) reduce to:
Given Under conditions of no DQH 2 oxidation to DQ (i.e. k o = 0), equations (9) (10) simplify to the following uncoupled ordinary differential equations:
Integrating both sides of equation (11) from x = 0 to x = L results in equation (13) which relates the rate of DQ reduction, ν (µmol⋅min 
Effect of hyperoxia on DQ reduction rate:
In the presence of cyanide, DQ reduction rate, ν, is equal to the steady state rate of determined by fitting equation (13) to the data shown in figure 5 . Table 5 shows that exposure to hyperoxia for 21 days significantly increased V max by ~ 107% and K ma by ~ 240% as compared to normoxic lungs.
Effects of hyperoxia on DQH 2 extravascular volume, vascular volume and vascular perfusion heterogeneity:
The extravascular volume of distribution accessible to DQH 2 , Q D (ml), the vascular volume, Q V (ml), and the relative dispersion of the vascular transit time
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distribution, RD V , were calculated from the data exemplified by figure 3 and FITC-dex tubing data (not shown) using the following equations:
where F is the perfusate flow rate (10 ml/min); t R , t D and t T are the respective mean transit times from bolus injection site to sample collection site for FITC-dex with the lung in place, (DQ + DQH 2 ) with the lung in place, and for FITC-dex with the lung removed;
σ R 2 and σ T 2 are the variances of the concentration versus times FITC-dex outflow curves with and without the lungs connected to the perfusion system, respectively. The different mean transit times and variances were estimated as previously described (3, 5) . The Q D is a virtual volume that is equal to the product of a physical tissue volume and a tissue-toperfusate partition coefficient (1). Table 5 shows that exposure to hyperoxia for 21 days decreased Q V by more than 30% and increased RD V by more than 40% as compared to normoxic lungs.
Discussion:
The results demonstrate that exposure to 85% O 2 for 21 days, but not for 48 hours, increases lung capacity to reduce DQ to DQH 2 . This increase is predominantly due to an increase in the rate of DQ reduction to DQH 2 , with no significant effect on DQH 2 oxidation. The results also suggest that NQO1 is the dominant DQ reductase since DQ reduction was dicumarol inhibitable in normoxic and hyperoxic lungs. The increase in wet weights and wet/dry weight ratios of 21-day hyperoxic lungs had no significant effect on the extravascular volume accessible to DQH 2 . As discussed next, these results are consistent with an increase in NQO1 activity in cells accessible to DQ from the vascular region in 21-day hyperoxic lungs.
Interpretation of the increase in V max , the maximum rate of DQ reduction to DQH 2 , in 21-day hyperoxic lungs:
In addition to increasing V max , exposure of rats to hyperoxia for 21 days had increased lung dry weights (table 1) , consistent with an increase in their lung cellular content, presumably due to a large increase in the number of interstitial cells (14) . This brought into question whether the increase in V max was simply the result of an increase in tissue mass (i.e. more cells) or an induction of NQO1 activity. As shown in A whole organ model which accounts for h c (t) was constructed based on the single capillary element model described in the Data Analysis section (5) . For the analysis, h c (t) was approximated using a random walk function and was accounted for in the whole organ model as previously described (1, 5). To evaluate the effects of h c (t) on the estimated values of V max and K ma , two organ models were created to simulate DQ reduction on passage through normoxic lungs (normoxic model) and 21-day hyperoxic lungs (hyperoxic model). For the normoxic model, V max was set at 2.0 µmol/min ( Table 7 shows the values of V max and K ma estimated by fitting equation (13) to the simulated DQ reduction rates in figure 6 and designated "recovered values", normalized to the corresponding values used in the model simulations and designated "actual values". For V max , the recovered values were within 10% of the actual values and were not sensitive to the relative dispersion of h c (t), RD c . However, for K ma the recovered values for normoxic and hyperoxic models were more than 5-fold and 11-
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fold larger than the actual value, respectively. Thus, the recovered K ma value for the hyperoxic model was more than double that for the normoxic model, although the actual value was the same for both. This suggests that K ma is sensitive to an increase in RD c , which could account for the increase in K ma in 21-day hyperoxic lungs as compared to normoxic lungs ( (14)) (24) . On the basis of the fraction of
DQ bound to BSA (~ 96% at 5% BSA) (1), the corresponding free K ma value for DQ reduction in normoxic lungs is ~ 1.8 µM which is also consistent with the 1.2 µM estimated by our previous studies (24) (table 2) . These results and the fact that the DQ reduction by the cultured pulmonary endothelial cells was dicumarol inhibitable are consistent with the pulmonary endothelium being a dominant site of DQ reduction in lungs. This is potentially important since the pulmonary capillary endothelium is primary target of O 2 toxicity, and since NQO1 has been shown to confer protection from oxidant stress (8, 9, 17, 30, 31, 33) .
The hyperoxia-induced increase in lung NQO1 activity may also have an impact on systemic organs by altering the redox status of compounds (e.g. quinones) passing through the lungs in preparation for entry into the systemic circulation. Depending on the physical and chemical properties of these compounds, the increase in lung NQO1 activity could represent an increased capacity to regenerate plasma anti-oxidants or production of prooxidant activity with potentially important implications for the physiology and pathophysiology of the systemic vascular system (1, 5, 10, 24). Normoxic and hyperoxic models simulate DQ reduction on passage through normoxic and 21-day hyperoxic lungs, respectively. V max is the maximum rate of DQ reduction to Band intensities were 2.0 ± 0.3 SE (n = 9) for normoxic lungs, 2.6 ± 0.4 (n = 9) for 48-hour hyperoxic lungs, and 6.1 ± 1.4 (n = 5) for 21-day hyperoxic lungs. during DQ infusion in the presence of cyanide (2 mM) for normoxic and hyperoxic lungs.
Values are mean ± SE, n = 4, 3 and 4 for normoxic lungs, 48-hour hyperoxic lungs, and 21-days hyperoxic lungs, respectively. Solid lines are fits of equation (13) to the data. 
